Smith TJ - Search Results

1

2006 update of recommendations for the use of white blood cell growth factors: an evidence-based clinical practice guideline.

Smith TJ, Khatcheressian J, Lyman GH, Ozer H, Armitage JO, Balducci L, Bennett CL, Cantor SB, Crawford J, Cross SJ, Demetri G, Desch CE, Pizzo PA, Schiffer CA, Schwartzberg L, Somerfield MR, Somlo G, Wade JC, Wade JL, Winn RJ, Wozniak AJ, Wolff AC. Smith TJ, et al. J Clin Oncol. 2006 Jul 1;24(19):3187-205. doi: 10.1200/JCO.2006.06.4451. Epub 2006 May 8. J Clin Oncol. 2006. PMID: 16682719

2

High-dose chemotherapy with autologous bone marrow transplantation for metastatic breast cancer.

Eddy DM, Hillner BE, Smith TJ, Desch CE. Eddy DM, et al. Among authors: smith tj. JAMA. 1992 Sep 23-30;268(12):1536-7. doi: 10.1001/jama.268.12.1536a. JAMA. 1992. PMID: 1518100 No abstract available.

3

The optimal timing of autologous bone marrow transplantation in Hodgkin's disease patients after a chemotherapy relapse.

Desch CE, Lasala MR, Smith TJ, Hillner BE. Desch CE, et al. Among authors: smith tj. J Clin Oncol. 1992 Feb;10(2):200-9. doi: 10.1200/JCO.1992.10.2.200. J Clin Oncol. 1992. PMID: 1531067

4

Oncologists and clinical trials: the profit motive.

Smith TJ, Desch CE. Smith TJ, et al. J Clin Oncol. 1992 Apr;10(4):672-3. doi: 10.1200/JCO.1992.10.4.672. J Clin Oncol. 1992. PMID: 1548531 No abstract available.

5

Efficacy and cost-effectiveness of autologous bone marrow transplantation in metastatic breast cancer. Estimates using decision analysis while awaiting clinical trial results.

Hillner BE, Smith TJ, Desch CE. Hillner BE, et al. Among authors: smith tj. JAMA. 1992 Apr 15;267(15):2055-61. JAMA. 1992. PMID: 1552641

6

Teaching specialty cancer medicine in rural hospitals: the cancer outreach program as a model.

Smith TJ, Desch CE, Simonson CJ, Kane NE. Smith TJ, et al. J Cancer Educ. 1991;6(4):235-40. doi: 10.1080/08858199109528127. J Cancer Educ. 1991. PMID: 1756108

7

Neutropenia-wise and pound-foolish: safe and effective chemotherapy in massively obese patients.

Smith TJ, Desch CE. Smith TJ, et al. South Med J. 1991 Jul;84(7):883-5. doi: 10.1097/00007611-199107000-00015. South Med J. 1991. PMID: 2068631

8

Free-riding and the prisoner's dilemma: problems in funding economic analyses of phase III cancer clinical trials.

Bennett CL, Smith TJ, George SL, Hillner BE, Fleishman S, Niell HB. Bennett CL, et al. Among authors: smith tj. J Clin Oncol. 1995 Sep;13(9):2457-63. doi: 10.1200/JCO.1995.13.9.2457. J Clin Oncol. 1995. PMID: 7545222 Review.

9

Defining treatment aims and end-points in older patients with cancer.

Desch CE, Smith TJ. Desch CE, et al. Among authors: smith tj. Drugs Aging. 1995 May;6(5):351-7. doi: 10.2165/00002512-199506050-00002. Drugs Aging. 1995. PMID: 7647424 Review. No abstract available.

10

Economic evaluation of a randomized clinical trial comparing vinorelbine, vinorelbine plus cisplatin, and vindesine plus cisplatin for non-small-cell lung cancer.

Smith TJ, Hillner BE, Neighbors DM, McSorley PA, Le Chevalier T. Smith TJ, et al. J Clin Oncol. 1995 Sep;13(9):2166-73. doi: 10.1200/JCO.1995.13.9.2166. J Clin Oncol. 1995. PMID: 7666075 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,734 results

Search Page